BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND MYC, c-Myc, 4609, ENSG00000136997
551 results:

  • 1. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer.
    Cao C; Xu Q; Zhu Z; Xu M; Wei Y; Lin S; Cheng S; Zhi W; Hong P; Huang X; Lin D; Cao G; Meng Y; Wu P; Peng T; Wei J; Ding W; Huang X; Sung W; Chen G; Ma D; Li G; Wu P
    Cancer Lett; 2024 Apr; 588():216809. PubMed ID: 38471646
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. HECW1 restrains cervical cancer cell growth by promoting DVL1 ubiquitination and downregulating the activation of Wnt/β-catenin signaling.
    Xu Z; Guo Y; Wang L; Cui J
    Exp Cell Res; 2024 Feb; 435(2):113949. PubMed ID: 38266865
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of miR-152 in cervical cancer and its influence on cisplatin resistance.
    Wu J; Chi X; Yang Q; Li J
    Afr Health Sci; 2023 Jun; 23(2):246-255. PubMed ID: 38223603
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.
    Huang YH; Wang WL; Wang PH; Lee HT; Chang WW
    Int J Biol Sci; 2024; 20(1):265-279. PubMed ID: 38164180
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Upregulation of FAM83F by c-myc promotes cervical cancer growth and aerobic glycolysis via Wnt/β-catenin signaling activation.
    Zhang C; Liu L; Li W; Li M; Zhang X; Zhang C; Yang H; Xie J; Pan W; Guo X; She P; Zhong L; Li T
    Cell Death Dis; 2023 Dec; 14(12):837. PubMed ID: 38104106
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and EMT in cervical cancer.
    Cheng Z; Wang H; Yang Z; Li J; Chen X
    BMC Cancer; 2023 Nov; 23(1):1128. PubMed ID: 37986152
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tripartite motif containing 33 demonstrated anticancer effect by degrading c‑myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells.
    Qi Y; Ma N; Zhang J
    Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37859625
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.
    Cui Z; Zou F; Wang R; Wang L; Cheng F; Wang L; Pan R; Guan X; Zheng N; Wang W
    World J Surg Oncol; 2023 Sep; 21(1):309. PubMed ID: 37759234
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diminazene aceturate-induced cytotoxicity is associated with the deregulation of cell cycle signaling and downregulation of oncogenes Furin, c-myc, and FOXM1 in human cervical carcinoma Hela cells.
    Gharbaran R; Sayibou Z; Atamturktur S; Ofosu-Mensah JJ; Soto J; Boodhan N; Kolya S; Onwumere O; Chang L; Somenarain L; Redenti S
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23527. PubMed ID: 37681557
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/β-catenin signaling pathway.
    Feng Q; Cui N; Li S; Cao J; Chen Q; Wang H
    FASEB J; 2023 Oct; 37(10):e23174. PubMed ID: 37668416
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway.
    Das A; Mathur SR; Kumar S; Bhatla N
    Sultan Qaboos Univ Med J; 2023 Aug; 23(3):303-310. PubMed ID: 37655078
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
    Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
    Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway.
    Zhang B; Ji J; Hu M; Zhou X; Nie Q; Xu H; Jiang C; Fu Y; Li L
    Am J Reprod Immunol; 2023 Aug; 90(2):e13743. PubMed ID: 37491917
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PSME3 induces radioresistance and enhances aerobic glycolysis in cervical cancer by regulating PARP1.
    Wei X; Sun K; Li S; Lin C; Wei Z
    Tissue Cell; 2023 Aug; 83():102151. PubMed ID: 37467687
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in Cervical cancer.
    Li QS; Zheng PS
    Cancer Res; 2023 Sep; 83(18):3095-3114. PubMed ID: 37350664
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway.
    Zheng P; Wu Y; Wang Y; Hu F
    Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. WIF1 was downregulated in cervical cancer due to promoter methylation.
    Wang Y; Yuan S; Ma J; Liu H; Huang L; Zhang F; Wang X
    Acta Biochim Pol; 2023 Jun; 70(2):419-423. PubMed ID: 37306343
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and myc.
    Wang A; Jin C; Wang Y; Yu J; Wang R; Tian X
    Mol Carcinog; 2023 Aug; 62(8):1228-1237. PubMed ID: 37306026
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer.
    Aghbash PS; Hemmat N; Baradaran B; Mokhtarzadeh A; Poortahmasebi V; Oskuee MA; Baghi HB
    Oncol Res; 2022; 30(3):99-116. PubMed ID: 37305016
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 28.